D-1541-2022 Class III Terminated
FDA drug recall D-1541-2022 was initiated by UNICHEM PHARMACEUTICALS USA INC on Sep 19, 2022 and is designated Class III. Reason for recall: Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets, The recall status is terminated (terminated Mar 2, 2023). Affected quantity: 18,960 bottles of 100.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 28, 2022
- Initiation Date
- Sep 19, 2022
- Termination Date
- Mar 2, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 18,960 bottles of 100
Product description
Clonidine Hydrochloride Tablets, USP, 0.3 mg, 100-count bottle, Rx Only, Manufactured by: UNICHEM LABORATORIES LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Manufactured for: UNICHEM PHARMACEUTICALS (USA), INC. East Brunswick, NJ 08816. NDC# 29300-137-01
Reason for recall
Product mix-up:0.2 mg strength Clonidine Hydrochloride Tablets, USP in a 100-count bottle of 0.3 mg strength Clonidine Hydrochloride Tablets,
Distribution pattern
Distributed Nationwide in the USA
Code information
Lot # GCLH22005, exp. date 02/29/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1541-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026